Do you have Alpha-1 Antitrypsin Deficiency? Do you want to participate in research? You may be able to participate in a research project to be contacted for future research studies. Compensation provided.

Are you interested in improving your physical health and wellbeing during or after cancer treatment? If so, our free 12- week exercise program might be a good fit for you! We are creating a registry of adults with a cancer diagnosis who have gone through our program.

Can we extend your life after the diagnosis of your cancer in the stomach, esophagus, or gastroesophageal junction by adding a third chemotherapy drug to the usual combination of two chemotherapy drugs? We are doing this study because we want to find out if this approach is better or worse than the usual approach for treatment of your cancer in the stomach, esophagus, or gastroesophageal junction. The usual approach is defined as care most people get for cancer in the stomach, esophagus, or gastroesophageal junction.

Do you have Stage II or III Breast cancer? If you have enough tissue from your breast cancer diagnosis to send for Mammaprint genomic testing, you may be able to take part in this research study. In this study, we want to learn more about adding an immunotherapy drug, durvalumab, to your chemotherapy treatment. The Mammaprint testing is conducted at no cost to you and the cost of durvalumab is covered.

Dear Colleagues and Students, We are conducting a study to understand how the quality of 2D and 3D ultrasound imaging of different organs (lungs, liver etc) can be improved. You may qualify if you 21 years and older Have no known lung and heart diseases Are not pregnant Participation involves A single laboratory visit Weighing and height measurement Being scanned with non-invasive ultrasound THERE IS NO DIRECT BENEFIT FROM PARTICIPATING IN THIS STUDY, BUT THE DATA WE COLLECT MYA HELP IMPROVE ULTRASOUND IMAGING FOR PATIENTS IN THE FUTURE For information please contact Oleksii Ostras by phone at 919-579-8328 or by email at oleksii@email.unc.edu. Pinton Laboratory, Joint Department of Biomedical Engineering (9212 Mary Ellen Jones Biulding)

Have you been diagnosed with metastatic triple negative breast cancer and have had progression of your cancer during or following your most recent cancer treatment? If so, you may be eligible for a study looking at the combination of two investigational drugs with doxil for patients with metastatic triple negative breast cancer.

Do you have intermediate risk prostate cancer and don't want to undergo surgery? You may be able to participate in a research study comparing therapy based on genetic testing.

Are you or do you plan to exclusively breastfeed your baby? We are conducting a research study to determine if eating avocados changes the nutrients in your milk and if so, how that affects your baby's recognition memory and overall development. Avocados will be provided!

Have you been diagnosed with relapsed or refractory multiple myeloma? If so you may be able to take part in a research study looking at the safety and efficacy of giving BMS-986393 to patients with multiple myeloma.

Do you have type one diabetes? Have you experienced low blood sugar? If you have T1DM, are using insulin, and have a CGM, you may be able to participate in a research study to see if an oral pill used with your current medications may help to lower the risk of hypoglycemia. Compensation provided.